Cross sectional study of use of alternative medicines in Chinese cancer patients

被引:42
作者
Liu, JM
Chu, HC
Chin, YH
Chen, YM
Hsieh, RK
Chiou, TJ
WhangPeng, J
机构
[1] Cancer Clinical Research Center, National Health Research Institute, Taipei
[2] Chest Medicine Department, Veterans' General Hospital, Taipei
[3] Division of Medical Oncology, Internal Medicine Department, Veterans' General Hospital-Taipei, Taipei
[4] Cancer Clinical Research Center, National Health Research Institute, Veterans General Hospital-Taipei, Taipei, Shipai Road, Section 2
关键词
alternative medicine; Chinese cancer patients; herbs; cross sectional study;
D O I
10.1093/jjco/27.1.37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to ascertain the prevalence of alternative medicine consumption in Chinese cancer patients on active conventional treatment, A cross sectional survey of 100 consecutive advanced cancer patients admitted to a cancer clinical trial referral unit were personally interviewed by their assigned oncology research nurse using a specially designed questionnaire, The results showed that 64% of our patients used indigenous Chinese medication, In all age groups except the over-70s (P = 0.043), >50% took such medication, more female (76%) than male (57.6%) patients (P = 0.323), Patients of all educational levels (P = 0.062) and religious backgrounds (P = 0.08) consumed alternative medicines, Duration of alternative medication consumption was less than three months in 50% of patients, with costs between US$40 and 2000/month for 70% of patients, Reasons cited for alternative medication consumption was hope that it might be of some benefit to their well being or disease control, and maybe even result in a miracle cure. Sources of advice on medication were mostly from strangers (by word of mouth), family, friends, the media, and infrequently from qualified professional Chinese doctors, Reasons for discontinuing such treatment were mostly given as lack of positive effect, In conclusion, Chinese cancer patients, willingly, rampantly and non-selectively seek out and consume alternative medications, with almost total ignorance of the medication consumed, oblivious to any potential side effects, and with little subjective benefit.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 18 条
  • [1] CORONARY HEART-DISEASE IN FRANCE
    BRIGGS, JC
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6954) : 611 - 611
  • [2] Cassileth B R, 1989, Oncology (Williston Park), V3, P29
  • [3] SURVIVAL AND QUALITY-OF-LIFE AMONG PATIENTS RECEIVING UNPROVED AS COMPARED WITH CONVENTIONAL CANCER-THERAPY
    CASSILETH, BR
    LUSK, EJ
    GUERRY, D
    BLAKE, AD
    WALSH, WP
    KASCIUS, L
    SCHULTZ, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1180 - 1185
  • [4] CONTEMPORARY UNORTHODOX TREATMENTS IN CANCER MEDICINE - A STUDY OF PATIENTS, TREATMENTS, AND PRACTITIONERS
    CASSILETH, BR
    LUSK, EJ
    STROUSE, TB
    BODENHEIMER, BJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) : 105 - 112
  • [5] PURSUIT AND PRACTICE OF COMPLEMENTARY THERAPIES BY CANCER-PATIENTS RECEIVING CONVENTIONAL TREATMENT
    DOWNER, SM
    CODY, MM
    MCCLUSKEY, P
    WILSON, PD
    ARNOTT, SJ
    LISTER, TA
    SLEVIN, ML
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6947) : 86 - 89
  • [7] CISPLATIN, VINBLASTINE, AND HYDRAZINE SULFATE IN ADVANCED, NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND PHASE-III STUDY OF THE CANCER AND LEUKEMIA GROUP-B
    KOSTY, MP
    FLEISHMAN, SB
    HERNDON, JE
    COUGHLIN, K
    KORNBLITH, AB
    SCALZO, A
    MORRIS, JC
    MORTIMER, J
    GREEN, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1113 - 1120
  • [8] THE PREVALENCE OF QUESTIONABLE METHODS OF CANCER-TREATMENT IN THE UNITED-STATES
    LERNER, IJ
    KENNEDY, BJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1992, 42 (03) : 181 - 191
  • [9] LIU CS, 1994, ENCY ESOTERIC PRESCR, P265
  • [10] PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER
    LOPRINZI, CL
    GOLDBERG, RM
    SU, JQ
    MAILLIARD, JA
    KUROSS, SA
    MAKSYMIUK, AW
    KUGLER, JW
    JETT, JR
    GHOSH, C
    PFEIFLE, DM
    WENDER, DB
    BURCH, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1126 - 1129